CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- SC 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
Page 9 of 31 · 615 filings